MDAngle

• Managing Patients With Early-Stage NSCLC: Always Bet With the Patient   Liza Villaruz, MD, puts a mentor's piece of advice into practice.
  Medscape, January 30, 2023
• Shifting the Perspective of Therapy Options in Early-Stage NSCLC   Liza Villaruz, MD, considers how her perspective on early-stage non–small cell lung cancer has changed over time.
  Medscape, January 30, 2023
• Early-Stage Non-Small Cell Lung Cancer: Mitigating the Rigors of Therapy   Mark Socinski, MD, considers the potential means to identify patients with lung cancer who may not need adjuvant therapy.
  Medscape, January 30, 2023
• A Look Back at the Rapidly Evolving Treatment Landscape for Early-Stage NSCLC   Mark Socinski, MD, recalls the limited scope of lung cancer staging that he witnessed early in his career.
  Medscape, January 30, 2023
• How Opportunity and Mentorship Launched a Career in Thoracic Oncology   Mark Socinski, MD, recalls what drove him toward working in lung cancer during his fellowship.
  Medscape, January 30, 2023
• Early-Stage Non-Small Cell Lung Cancer: Advice to Oncologists Beginning Their Careers   Thomas Stinchcombe, MD, remarks on the costs of an excess of professional aspiration.
  Medscape, January 30, 2023
• Early-Stage Non-Small Cell Lung Cancer: Addressing the Imperfections   Thomas Stinchcombe, MD, reflects on the successes and deficiencies of treatment for early-stage non-small cell lung cancer.
  Medscape, January 30, 2023
• Thinking Big Picture in the Management of Patients With Early-Stage Non-Small Cell Lung Cancer   Kristin Higgins, MD, offers advice to early-career oncologists.
  Medscape, January 30, 2023
• Witnessing Advances in Management Options for Patients With Early-Stage Non-Small Cell Lung Cancer   Kristin Higgins, MD, thinks back to early experiences in treating patients with early-stage non-small cell lung cancer (NSCLC) and the advances that have been made since.
  Medscape, January 30, 2023
• Analyzing Disparities in the Treatment of Mantle Cell Lymphoma   Yazeed Sawalha, MD, discusses a study that analyzed how health disparities affect the likelihood of undergoing consolidated autologous stem cell transplant for mantle cell lymphoma.
  Medscape, January 26, 2023
• Recognizing the Many Faces of Mantle Cell Lymphoma   Ann S. LaCasce, MD, MMSc, looks back and describes what she wishes she understood about mantle cell lymphoma at the start of her career.
  Medscape, January 23, 2023
• Tracing a Memorable Patient's Journey With Mantle Cell Lymphoma   Ann S. LaCasce, MD, recalls the progress of a patient with mantle cell lymphoma for 14 years.
  Medscape, January 23, 2023
• Recognizing the Heterogenous Nature of Mantle Cell Lymphoma   Kami Maddocks, MD, explores the diverse disease course of mantle cell lymphoma and the importance of finding the right therapy for the right patient.
  Medscape, January 19, 2023
• A Patient Experience That Illustrates the Changing Treatment Landscape in Mantle Cell Lymphoma   Suchitra Sundaram, MD, recounts the lack of therapeutic options in mantle cell lymphoma at the beginning of her career and the quickly evolving landscape thereafter.
  Medscape, January 19, 2023
• An Impactful Patient Experience That Has Altered My Approach to Mantle Cell Lymphoma   Suchitra Sundaram, MD, recalls one of her earliest interactions with a patient with mantle cell lymphoma.
  Medscape, January 18, 2023
• Mantle Cell Lymphoma: Understanding the Ferocity of Relapse   Tycel J. Phillips, MD, reflects on the variability in disease course for mantle cell lymphoma.
  Medscape, January 12, 2023
• Advanced and Metastatic Breast Cancer: A Shift in Thinking   Sara M. Tolaney, MD, reflects on therapeutic strides in the treatment of advanced and metastatic breast cancer.
  Medscape, January 06, 2023
• Achieving a Long Duration of Response in Metastatic Breast Cancer Through Powerful Novel Therapies   Sara M. Tolaney, MD, MPH, recounts a patient with metastatic triple-negative breast cancer from her early days of clinical practice.
  Medscape, January 06, 2023
• A 'Stressed-Out' Healthcare Infrastructure Reveals Disparities in Availability of Care   Kevin M. Kalinsky, MD, addresses the disparities inherent within the healthcare infrastructure that limit access to care for patients with advanced breast cancer.
  Medscape, January 06, 2023
• An Impactful Experience With a Patient With Metastatic Breast Cancer   Kevin M. Kalinsky, MD, considers the impact of an antibody-drug conjugate in a patient with HER2-low breast cancer.
  Medscape, January 06, 2023